chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a healthcare worker referring to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. on 06-JUL-2015 the patient was vaccinated with improperly stored RECOMBIVAX HB injection (lot # J004700, exp 26-NOV-2015, strength, dose and route unspecified). The reporter did not stated if the administered RECOMBIVAX HB was the first dose in the series. No concomitant medication was reported. No adverse symptoms reported. The outcome of the event was unknown. There were no product quality complaints (PQC) involved. This is one of several reports received from the same reporter. Additional information has been requested.
I have had extreme pain in my right arm which began approximately 30 days after my 3rd vaccine (booster) it got so bad I was losing sleep and losing use of my arm and hand. I had it checked out and was sent to an orthopedic doctor. X-rays we?re done, am MRI was done along with many other tests and nothing could explain the pain as my arm shoulder and rotator cuff are in excellent condition. I was given steroid shots for 15 months and it only worked on the pain temporarily. The doctor does not want to give me more in fear of more damage so now I am in pain 24 hours a day and again losing use of my right arm and hand.
Patient got 1st dose on 10 May 2021, and wants 2nd shot today 28jun2021; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient got 1st dose on 10 May 2021, and wants 2nd shot today 28jun2021) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient got 1st dose on 10 May 2021, and wants 2nd shot today 28Jun2021). On 10-May-2021, PRODUCT DOSE OMISSION ISSUE (Patient got 1st dose on 10 May 2021, and wants 2nd shot today 28jun2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were provided.
Dose 1- injection site pain (mild for 4-5 days), headache (intermittent for 2-3 days).  Tylenol taken for   Dose 2-  Day 1 - low grade fever (100 degrees-  lasted 12 hours), headache (constant/moderate- lasted 24 hours) Day 2- moderate injection site pain with swelling and red, itchy rash, swollen lymph node over collar bone.  Continued throughout day 2. Tylenol taken both days
no adverse event; improperly stored doses of PEDVAX HIB and ROTATEQ were administered to two patients; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. No information about the patient's pertinent medical history, concurrent conditions, concomitant medications, or drug reactions or allergies was provided.   On 03-OCT-2022, the patient was vaccinated with improperly stored haemophilus B conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) quantity 1, lot #U034522, expiration date: 22-JUN-2024, used as directed to prevent haemophilis influenza B infection (strength, route of administration, vaccination scheme frequency, anatomical location, and dose were not reported); and  rotavirus vaccine, live, oral, pentavalent (ROTATEQ), 2 milliliter oral liquid, quantity 1, lot #W011278, expiration date: 01-NOV-2023, administered orally, used as directed to prevent roatvirus infection (vaccination scheme frequency, and dose were not reported) (Product storage error). Temperature excursion as following: 34.3 Fahrenheit (F); time frame: 1 hour 18 minutes. There was no previous temperature excursion. No additional adverse event was reported (no adverse event).  This is one of two reports received from the same reporter.
Information has been received from an approximately 69 year old female who reported that approximately "9 or 10" years ago, she was vaccinated with PNEUMOVAX. (lot # not reported) Concomitant therapy included influenza virus vaccine (unspecified). "On the same day of the vaccinations" the patient developed an injection site rash. The rash appeared on the same both of the injection sites of PNEUMOVAX and the influenza virus vaccine (unspecified). The patient reported that she was seen by a nurse. On an unreported date the patient recovered from injection site rash. No further information is available. Additional information is not expected.
Fever, malaise, nasal congestion since several hours after influenza vaccine. Still on-going four days later.
Wanted to report this patient had received the J&J vaccine on 4-6-21 then came in to get a Pfizer vaccine on 5-10-2021. We gave the patient the vaccine then caught the mistake when we were billing at the end of the night. I spoke with the patient he is feeling fine and knows he does not need a second Pfizer dose.
Pfizer 3/12/21, 4/9/21. Positive on 6/27/22
Sustained redness, swelling, heat, and itching at the injection site.  Similar to localized allergic reactions due to direct extended sun exposure.  Inflammation approximately 7-10cm in diameter.
Patient had already received a Pfizer booster 11 months after her 2nd Pfizer vaccine.  Then received a 2nd booster 3 months after the 1st booster.
Approximately 5-6 days after first covid vaccine I developed a small patch (3 bumps) of red itchy and tender bumps (vesicular blisters) on left side of torso.  The following day I developed 6 additional red itchy tender bumps along the left side of my back at the same level (dermatome) as the bumps on the front with tenderness and discomfort in the surrounding area leading down into left groin.  Have developed a few smaller and less significant bumps after again only on left side of body.  Saw primary care physician about 6 days after first symptoms developed and was diagnosed with shingles.
Intermittent dizziness - not full on vertigo, but just a woozy feeling in head  First and second doses of Pfizer vaccine had instant dizziness with an awful reaction to second dose. Chills, fever, aches, nausea, dizzy.   Dizziness came back intermittently on March 8 along with on and off bilateral tingling of hands and back of calves along with occasional feet.  It has slightly gotten better but still dealing with it intermittently.  Talked to multiple doctors and had blood tests ran- all was normal. One said could very much be reaction to vaccine.
Herpes zoster; This spontaneous report was received from a physician via field representative refers to a currently 3 years old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were unknown. On an unknown date (at the age of 12 months), the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (strength, dose, route, anatomical location, lot # and expiration date not reported) for prophylaxis. On an unknown date, the patient experienced herpes zoster. The patient sought medical attention. No lab diagnostic or study was performed. It was unknown if any treatment was given for the event. No product quality complaint (PQC) was present. The outcome of herpes zoster was reported as resolved.  The causality assessment was not provided by the reporter.
1st dose in 2019 and has not received dose 2; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2019).   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter was Clinic Director and stated that, the patient received the first dose of Shingrix and had not received dose two till the time of reporting, which led to incomplete course of vaccination. The reporter consented to follow up.
This spontaneous report as received from a health care worker refers to a unspecified number of patients of unknown age. The patients medical history was not reported. On an unknown date the patient was vaccinated with ROTATEQ. Concomitant medications were reported. On an unknown date the unspecified number of patients received ROTATEQ doses that were stored at 34 Fahrenheit (F) for 7 hours. No adverse effects were reported. The outcome of received ROTATEQ vaccine doses that were stored at 34F for hours and no adverse effects reported was unknown. The healthcare worker stated that no patient or lot information was available. This case is linked to 1406USA003227, 1406USA003839, 1406USA003840 and 1406USA003841 (same reporter link). Additional information has been requested.
Pt had a seizure about 3 days after taking the vax.  Pt had not had a seizure for over a year.  His father gave him a cool rag and extra seizure medicine.  His father contacted his Neurologist.  He was told just to keep and eye on him and give him extra seizure medicine if needed.
Information has been received from a physician concerning a 17 year old female patient with a penicillin allergy, who on 20-FEB-2008 ("five weeks ago"), was vaccinated with the first dose of GARDASIL (lot # not reported).  In March 2008, 3 to 4 weeks after the vaccination, the patient developed a rash.  The rash was very painful and was confirmed by biopsy as erythema nodosum.  At the time of this report, the patient had not recovered.  The physician felt that erythema nodosum which was very painful, was considered to be disabling.  Additional information has been requested.
Shortly  after the first dose of Pfizer vaccine, my upper lip, upper gums ,nose, eyelids got swollen and the back of my tongue felt sore. At 11:00 pm same day , when I went to take my low dose aspirin and vitamin D gel caps with water, I had difficulty swallowing them. The side effects lasted until the following day by early evening. I left several ,messages with VAERS, to report these symptoms and never got a call back.
(L) arm SQ site redness, heat. Pt saw physician who prescribed "Steroid Inj and BENADRYL OD
Arm pain; Full body weakness; Full body aches; Head aches; Dizziness; anxiety/nervousness; Mental blur; Coughing; soar throat; Joint pain; Runny stuffy nose; sneezing; This is a spontaneous report from a contactable other healthcare professional. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 06Apr2021 at 15:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no past medical history. The patient did not have allergies to any medications, food, or other products. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken on an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 15:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 16:30, the patient experienced arm pain, full body weakness and aches, headaches, dizziness, anxiety, nervousness, mental blur, coughing, sore throat, joint pain, runny stuffy nose, and sneezing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events arm pain, full-body weakness and aches, headaches, dizziness, anxiety/nervousness, mental blur, coughing, sore throat, joint pain, runny stuffy nose, and sneezing were recovered with sequelae.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Starting on Friday, Saturday, Sunday I noticed that my vision was not as clear as my right and my left eye felt different from my right.  On  Monday, 10/26/15 I went to my optician office and had testing performed and was referred to neurologist ophthalmologist.  On 10/28/15 I saw the specialist who prescribed Dexamethasone, 4mg, and ordered MRI's, carotid ultrasound, lab work.  On 10/29/15 the tests were performed.  On 11/4/15 - I had an appt. with my PCP who ordered a chest x-ray, additional lab work and referred me to a Rheumatologist due to 1989 I was diagnosed with sarcoidosis.  11/6/15 - Appt. with rheumatologist - negative for sarcoidosis. 12/29/15 - I had an appointment for a second opinion with neurologist ophthalmologist.  At this appointment, slight improvement although I do not notice it with my vision.  I wore the mono vision contact lenses and with my current vision in my left eye, I cannot continue to wear them because they do not help with my current vision and my job requires me to be at the computer.  I have an appointment this coming Monday to get a new prescription to help me with my current vision status to see better.  Hopefully, in a few months my vision will return and some of the darkness will be gone.
Patient felt weak and got really sweaty (cold sweat) , then he vomited for a few minutes and felt better.  The sick feeling came on within 2 minutes of the administration and he felt better after vomiting
C/o pain/warmth to right upper arm 2 hours after pneumonia vacc. Dx: cellulitis right arm after pneumonia vacc. Tx: Cipro XR 1000 mg qu #5 and Ultram every 6 hours prn pain #30.
Rash started forming on right wrist first around 4pm. Continuing itching right wrist ay night. Took zyrtec and applied1% hydrocortisone and motrin and went to bed. Woke with itching at 4 am took zyrtec, applied hydrocortisone. Tash on right forearm,started on nech. Showered and attempted driving to work, turned around due to worsening rash and went to OSAu ED. Got iv fluids, benadryl, pepcid and steroids iv. Now at home steroids prescribed for 5 more days.  Off work today and  tomorrow .
Patient complaining of (R) side of neck, (R) shoulder, (R) arm pain plus inability to move above mentioned areas.
Information has been received from a health professional concerning a 16 year old female who was vaccinated with the third dose of GARDASIL. The mother of the patient stated that shortly after vaccination, the patient experienced swelling at the injection site and redness at the injection site. The patient sought unspecified medical attention. At the time of report, the patient was recovering from swelling at the injection site and redness at the injection site. No other information is available. Additional information has been requested.
I had delayed urticaria (no itch) on my neck, arms & back. It appeared on the 2nd day after my vaccine was administered. This was despite taking benadryl after I received my shot. I took benadryl each day after as a preventative and the rash still came.  I have developed this type of rash every time I get a covid vaccine, usually on the 2nd day. It usually takes about 3 or 4 days to recede.
Patient was administered the COVID19 vaccine and 5 minutes later, while in the observation chair, fainted and fell to the ground. His mother was present with him and the pharmacy staff rushed over to help. He came to after a minute or 2, but the paramedics were called immediately. Patient was a sweaty, hot. Paramedics arrived, did some test and said his blood pressure was low. They proceeded to take him to the hospital. Mom called around 3pm 6/17 and informed the pharmacy staff he was administered fluid, they ran more tests and he was waiting to be released.
10/2022 - severe hives, cough, nasal discharge, fever. Sought medical care from pediatrician. Respiratory panel, tested positive for RSV. Treated with diphenhydramine and Zyrtec. Hives persisted for 2+weeks.  1/15/2023 - cough, fever, fatigue, nasal discharge. Tested positive for COVID 1/15/2023. Cough has persisted for 4.5 weeks and still present. Sought care 2/7/2023, prescribed albuterol inhaler q4hrs.
Stroke like symptoms. Had to hospitalized due to uncontrollable blood pressure. Then had another episode a week later of BP but was released. The next week had to be hospitalized again for a week. On the 28th had to go back to ER due to BP running in 230/130. Both shots were given to me on a Friday and had to go ER on Sunday.
COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 26Sep2023 as dose 1, single (Batch/Lot number: unknown) at the age of 31 years for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (non-serious) with onset Sep2023, outcome "not recovered", described as "COVID 19 Treatment". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of covid-19.  Additional information: Patient took Paxlovid from  29Sep2023 to 03Oct2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
24hr post vax pt exp itching around arm, neck, hive, rash all over body-MD rx allergy pills-itching over entire body lasting 48-72hr
Patient received her first Janssen covid vaccine. Ten  minutes after receiving the vaccine, she fainted and fell out of her chair. At that time, the pharmacist, went to check on her and call the paramedics. Patient regained consciousness within 60 seconds. The paramedics arrived and provided her with care. After an hour, the patient said she felt better. She declined the paramedics offer to transport to the hospital. She left the building with her mother.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Oct2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 61 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 including Paxlovid from 13May2023 to 17May2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Lt arm red warm to touch. Fever noted. Slightly swollen, radiating down arm.
Information has been received from a nurse practitioner referring to a patient of unknown gender. Concurrent condition and medical history were not reported. On 06-FEB-2015 the 4 month old patient was vaccinated with a dose of GARDASIL (dose 0.5 ml, lot # and expiration date were unknown) intramuscularly. No adverse events were reported. Additional information has been requested.
Headache, sore throat, vomit x 1, fevers, fatigue.
Very bad flu-like illness; Fever; This is a spontaneous report from a Pfizer sponsored program . A contactable 50-year-old female consumer (patient) reported for herself. A 50-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration in Apr2021 (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient (50 years old) mentioned that she had the Pfizer BioNTech COVID-19 vaccine last April and experienced typical symptoms you hear like very bad flu-like illness for a good 24-36 hours and then fever, what they have been reporting in the news, so caller thought it was not necessary to report her experience". Caller mentioned that she knows "some people do get strong reactions and some people did not, but she cannot do that to her daughter. The clinical outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. .; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021857083 same reporter/drug, different patient/AE;US-PFIZER INC-2021857084 same reporter/drug, different patient/AE;US-PFIZER INC-2021857081 same reporter/drug, different patient/AE;US-PFIZER INC-2021857082 same reporter/drug, different patient/AE
rt arm became hot & swollen that evening;Saturday AM heat applied & Ibuprofen taken;Friday evening took DPH;original swelling was from rt shoulder to elbow;